BVT Aktienanleihe SNW 28.06.2024/ DE000VU68V78 /
10/05/2024 08:54:23 | Chg.+0.43 | Bid22:00:39 | Ask22:00:39 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
80.33EUR | +0.54% | - Bid Size: - |
- Ask Size: - |
SANOFI SA INHABER ... | 115.00 EUR | 28/06/2024 | Call |
GlobeNewswire
10/05
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire
08/05
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
07/05
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
02/05
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
25/04
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire
23/04
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire
17/04
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
GlobeNewswire
10/04
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Upda...
GlobeNewswire
09/04
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targe...
GlobeNewswire
14/03
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Busi...